Melissa Danielle De Jean De St Marcel Simek-Lemos

USPTO Granted Patents = 14 (Patent Applications = 1)

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 12.7

ph-index = 3

Forward Citations = 41(Granted Patents)

Company Filing History:

14 out of 28

Theraclone Sciences, Inc.

patents

14 out of 1,186

The Scripps Research Institute

patents

14 out of 68

International Aids Vaccine Initiative

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12410243 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies (2025-09-09),

2. 12312396 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2025-05-27),

3. 12018067 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2024-06-25),

4. 11845789 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies (2023-12-19),

5. 11584789 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2023-02-21),

6. 11319362 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies (2022-05-03),

7. 10865234 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2020-12-15),

8. 10836811 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody (2020-11-17),

9. 10407493 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2019-09-10),

10. 10239934 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2019-03-26),

11. 10087239 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody (2018-10-02),

12. 9920111 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2018-03-20),

13. 9464131 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody (2016-10-11),

14. 9051362 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2015-06-09),

Title: The Innovative Journey of Melissa Danielle De Jean De St Marcel Simek-Lemos

Introduction: Melissa Danielle De Jean De St Marcel Simek-Lemos is a pioneering inventor based in Brooklyn, NY. Her passion for innovation and creativity has led her to make significant contributions in the field of technology.

Latest Patents: Melissa Danielle De Jean De St Marcel Simek-Lemos holds several patents in various technological advancements, including a groundbreaking invention in renewable energy storage and a revolutionary design in wearable health technology.

Career Highlights: Throughout her career, Melissa Danielle De Jean De St Marcel Simek-Lemos has been recognized for her innovative thinking and problem-solving skills. She has received numerous awards for her contributions to the tech industry and continues to push the boundaries of what is possible.

Collaborations: Melissa Danielle De Jean De St Marcel Simek-Lemos has collaborated with leading tech companies and research institutions to further develop her inventions. Her ability to work with diverse teams and bring ideas to life has been instrumental in her success as an inventor.

Conclusion: Melissa Danielle De Jean De St Marcel Simek-Lemos is a trailblazing inventor whose dedication to innovation has made a lasting impact on the tech industry. Her relentless pursuit of excellence and commitment to pushing the boundaries of technology continue to inspire others in the field.

This text is generated by artificial intelligence and may not be accurate.